Combining PIM inhibition with JAK2 inhibition synergistically induced apoptosis and sensitized MPN cells to JAK2 inhibition, including synergistically suppressing the neoplastic growth of primary cells from MPN patients [172,173,174]. Here, JAK2 is linked to myeloproliferative disorder.